Intravascular Ultrasound Platform Leverages AI for Superior Imaging and Streamlined Workflows

IVUS has been gaining traction, especially in coronary interventions, with solid evidence from clinical trials backing its use in both coronary and peripheral interventions. However, traditional IVUS systems, primarily designed for coronary applications and only secondarily for peripheral vascular use, have faced limitations in terms of image quality, interpretation, and workflow efficiency. These drawbacks have hindered its broader adoption despite its proven clinical benefits, and there's been little innovation to overcome these challenges. Now, an advanced IVUS platform technology leverages artificial intelligence (AI) to enable superior imaging and streamlined workflows.

Evident Vascular (San Jose, CA, USA) is developing the advanced technology to expand the use of IVUS, increase market reach, and enhance clinical outcomes through quicker, more precise diagnostic and treatment decisions. The Evident Vascular Guidance System represents a significant leap forward in IVUS innovation, being the first of its kind specially designed for today’s peripheral vascular interventional procedures. This system utilizes AI, setting new benchmarks in imaging quality, interpretation accuracy, user-friendliness, and navigating the peripheral vasculature. The Evident Vascular Guidance System aims to empower clinicians with clear, confident diagnostics and interventions, positioning itself as a vital tool in managing peripheral vascular interventions. The Evident Vascular Guidance System can support the use of IVUS in managing peripheral vascular interventions, ensuring that patients with peripheral vascular disease get the most effective treatments available.

Related Links:
Evident Vascular